Modalis Therapeutics Corporation (4883.T)

JPY 103.0

(-1.9%)

Long Term Debt Summary of Modalis Therapeutics Corporation

  • Modalis Therapeutics Corporation's latest annual long term debt in 2023 was 412.5 Million JPY , down 0.0% from previous year.
  • Modalis Therapeutics Corporation's latest quarterly long term debt in 2024 Q2 was 162.5 Million JPY , down -55.17% from previous quarter.
  • Modalis Therapeutics Corporation reported annual long term debt of - JPY in 2022, down -100.0% from previous year.
  • Modalis Therapeutics Corporation reported annual long term debt of 5.76 Million JPY in 2021, down 0.0% from previous year.
  • Modalis Therapeutics Corporation reported quarterly long term debt of 162.5 Million JPY for 2024 Q2, down -55.17% from previous quarter.
  • Modalis Therapeutics Corporation reported quarterly long term debt of 412.5 Million JPY for 2023 FY, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Modalis Therapeutics Corporation (2023 - 2019)

Historical Annual Long Term Debt of Modalis Therapeutics Corporation (2023 - 2019)

Year Long Term Debt Long Term Debt Growth
2023 412.5 Million JPY 0.0%
2022 - JPY -100.0%
2021 5.76 Million JPY 0.0%
2020 - JPY 0.0%
2019 - JPY 0.0%

Peer Long Term Debt Comparison of Modalis Therapeutics Corporation

Name Long Term Debt Long Term Debt Difference
Pharma Foods International Co., Ltd. 1.23 Billion JPY 66.491%
Takeda Pharmaceutical Company Limited 4476.5 Billion JPY 99.991%
Sumitomo Pharma Co., Ltd. 133.36 Billion JPY 99.691%
Shionogi & Co., Ltd. 8.75 Billion JPY 95.287%
Wakamoto Pharmaceutical Co.,Ltd. - JPY -Infinity%
Nippon Shinyaku Co., Ltd. 1.15 Billion JPY 64.193%
Kaken Pharmaceutical Co., Ltd. - JPY -Infinity%
Eisai Co., Ltd. 134.77 Billion JPY 99.694%
Morishita Jintan Co., Ltd. 106 Million JPY -289.151%
Hisamitsu Pharmaceutical Co., Inc. 76 Million JPY -442.763%
Mochida Pharmaceutical Co., Ltd. - JPY -Infinity%
Fuso Pharmaceutical Industries,Ltd. 7.02 Billion JPY 94.125%
Nippon Chemiphar Co., Ltd. 13.34 Billion JPY 96.909%
Tsumura & Co. 54.37 Billion JPY 99.241%
Kissei Pharmaceutical Co., Ltd. - JPY -Infinity%
Torii Pharmaceutical Co., Ltd. 22 Million JPY -1775.0%
Towa Pharmaceutical Co., Ltd. 189.12 Billion JPY 99.782%
Fuji Pharma Co., Ltd. 11.92 Billion JPY 96.541%
Zeria Pharmaceutical Co., Ltd. 7.94 Billion JPY 94.807%
KYORIN Holdings, Inc. 435 Million JPY 5.172%
Taiko Pharmaceutical Co.,Ltd. 2.74 Billion JPY 84.951%
Daito Pharmaceutical Co.,Ltd. 4.66 Billion JPY 91.165%
SymBio Pharmaceuticals Limited - JPY -Infinity%
MedRx Co., Ltd - JPY -Infinity%
Mizuho Medy Co.,Ltd. - JPY -Infinity%
Solasia Pharma K.K. 27 Million JPY -1427.778%
ASKA Pharmaceutical Holdings Co.,Ltd. 4.5 Billion JPY 90.844%
Sawai Group Holdings Co., Ltd. 66.84 Billion JPY 99.383%
Cyfuse Biomedical K.K. 345 Million JPY -19.565%
Toho Holdings Co., Ltd. 28.16 Billion JPY 98.535%
Koa Shoji Holdings Co.,Ltd. 1.59 Billion JPY 74.079%